Clinical Trials Browser

Phase 1/2 × INDUSTRY × Therapeutics × Clear all

NCT04020185 2024-12-11

Safety and Efficacy Study of IMSA101 in Refractory Malignancies

Phase 1/2 Completed

40 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

NCT01892293 2019-01-10

CT Antigen TCR-Engineered T Cells for Myeloma

Phase 1/2 Terminated

6 enrolled 10 charts

Multiple Myeloma